| Kelly G. Huller |
GMED |
Class A Common Stock |
Sale |
-100% |
$1,890,000 |
$94.50 |
-20,000 |
0 |
25 Feb 2026 |
Direct |
| Kelly G. Huller |
GMED |
Class A Common Stock |
Options Exercise |
|
|
|
20,000 |
20,000 |
25 Feb 2026 |
Direct |
| Kelly G. Huller |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Options Exercise |
-50% |
|
|
-20,000 |
20,000 |
25 Feb 2026 |
Direct |
| Kelly G. Huller |
GMED |
Class A Common Stock |
Sale |
-100% |
$876,700 |
$87.67 |
-10,000 |
0 |
12 Feb 2026 |
Direct |
| Kelly G. Huller |
GMED |
Class A Common Stock |
Options Exercise |
|
|
|
10,000 |
10,000 |
12 Feb 2026 |
Direct |
| Kelly G. Huller |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Options Exercise |
-100% |
|
|
-10,000 |
0 |
12 Feb 2026 |
Direct |
| Leslie Norwalk V |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Award |
|
|
|
15,000 |
15,000 |
21 Jan 2026 |
Direct |
| Keith W. Pfeil |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Award |
|
|
|
100,000 |
100,000 |
21 Jan 2026 |
Direct |
| Kyle Kline |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Award |
|
|
|
30,000 |
30,000 |
21 Jan 2026 |
Direct |
| David C. Paul |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Award |
|
|
|
100,000 |
100,000 |
21 Jan 2026 |
Direct |
| Robert Andrew Douglas |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Award |
|
|
|
15,000 |
15,000 |
21 Jan 2026 |
Direct |
| Dan Lemaitre |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Award |
|
|
|
15,000 |
15,000 |
21 Jan 2026 |
Direct |
| Ann D. Rhoads |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Award |
|
|
|
15,000 |
15,000 |
21 Jan 2026 |
Direct |
| John A. DeFord |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Award |
|
|
|
15,000 |
15,000 |
21 Jan 2026 |
Direct |
| Dan Wolterman |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Award |
|
|
|
15,000 |
15,000 |
21 Jan 2026 |
Direct |
| David D. Davidar |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Award |
|
|
|
15,000 |
15,000 |
21 Jan 2026 |
Direct |
| Kelly G. Huller |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Award |
|
|
|
40,000 |
40,000 |
21 Jan 2026 |
Direct |
| Zarrilli Stephen T. |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Award |
|
|
|
15,000 |
15,000 |
21 Jan 2026 |
Direct |
| James R. Tobin |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Award |
|
|
|
15,000 |
15,000 |
21 Jan 2026 |
Direct |
| Kyle Kline |
GMED |
Class A Common Stock |
Sale |
-100% |
$363,353 |
$101.10 |
-3,594 |
0 |
08 Jan 2026 |
Direct |
| Kyle Kline |
GMED |
Class A Common Stock |
Options Exercise |
|
|
|
3,594 |
3,594 |
08 Jan 2026 |
Direct |
| Kyle Kline |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Options Exercise |
-47.9% |
|
|
-3,594 |
3,906 |
08 Jan 2026 |
Direct |
| Leslie Norwalk V |
GMED |
Class A Common Stock |
Sale |
-16.1% |
$202,200 |
$101.10 |
-2,000 |
10,419 |
08 Jan 2026 |
Direct |
| Leslie Norwalk V |
GMED |
Class A Common Stock |
Sale |
-24.4% |
$355,400 |
$88.85 |
-4,000 |
12,419 |
12 Dec 2025 |
Direct |
| David C. Paul |
GMED |
Class A Common Stock |
Options Exercise |
132% |
|
|
34,375 |
60,417 |
08 Dec 2025 |
Direct |
| David C. Paul |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Options Exercise |
-100% |
|
|
-34,375 |
0 |
08 Dec 2025 |
Direct |
| Kyle Kline |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Options Exercise |
-97.9% |
|
|
-4,896 |
104 |
01 Dec 2025 |
Direct |
| Kelly G. Huller |
GMED |
Class A Common Stock |
Sale |
-100% |
$675,000 |
$90.00 |
-7,500 |
0 |
25 Nov 2025 |
Direct |
| Kelly G. Huller |
GMED |
Class A Common Stock |
Options Exercise |
|
|
|
7,500 |
7,500 |
25 Nov 2025 |
Direct |
| Kelly G. Huller |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Options Exercise |
-100% |
|
|
-7,500 |
0 |
25 Nov 2025 |
Direct |
| David D. Davidar |
GMED |
Class A Common Stock |
Sale |
-4.62% |
$2,150,005 |
$86.00 |
-25,000 |
516,275 |
12 Nov 2025 |
Direct |
| David D. Davidar |
GMED |
Class A Common Stock |
Options Exercise |
4.84% |
|
|
25,000 |
541,275 |
12 Nov 2025 |
Direct |
| David D. Davidar |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Options Exercise |
-100% |
|
|
-25,000 |
0 |
12 Nov 2025 |
Direct |
| Zarrilli Stephen T. |
GMED |
Class A Common Stock |
Sale |
-100% |
$2,107,258 |
$84.29 |
-25,000 |
0 |
11 Nov 2025 |
Direct |
| Zarrilli Stephen T. |
GMED |
Class A Common Stock |
Options Exercise |
|
|
|
25,000 |
25,000 |
11 Nov 2025 |
Direct |
| Zarrilli Stephen T. |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Options Exercise |
-100% |
|
|
-25,000 |
0 |
11 Nov 2025 |
Direct |
| Ann D. Rhoads |
GMED |
Class A Common Stock |
Sale |
-11.5% |
$170,000 |
$85.00 |
-2,000 |
15,384 |
10 Nov 2025 |
Direct |
| Ann D. Rhoads |
GMED |
Class A Common Stock |
Sale |
-31.5% |
$648,000 |
$81.00 |
-8,000 |
17,384 |
07 Nov 2025 |
Direct |
| Ann D. Rhoads |
GMED |
Class A Common Stock |
Sale |
-28.3% |
$584,600 |
$58.46 |
-10,000 |
25,384 |
15 Sep 2025 |
Direct |
| Keith W. Pfeil |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Award |
|
|
|
40,000 |
40,000 |
18 Jul 2025 |
Direct |
| Kyle Kline |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Award |
|
|
|
20,909 |
20,909 |
18 Jul 2025 |
Direct |
| Ann D. Rhoads |
GMED |
Class A Common Stock |
Sale |
-17.5% |
$590,100 |
$78.68 |
-7,500 |
35,384 |
28 Feb 2025 |
Direct |
| David D. Davidar |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Award |
|
|
|
15,000 |
15,000 |
23 Jan 2025 |
Direct |
| John A. DeFord |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Award |
|
|
|
15,000 |
15,000 |
23 Jan 2025 |
Direct |
| Robert Andrew Douglas |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Award |
|
|
|
15,000 |
15,000 |
23 Jan 2025 |
Direct |
| Kelly G. Huller |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Award |
|
|
|
40,000 |
40,000 |
23 Jan 2025 |
Direct |
| Dan Lemaitre |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Award |
|
|
|
15,000 |
15,000 |
23 Jan 2025 |
Direct |
| Leslie Norwalk V |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Award |
|
|
|
15,000 |
15,000 |
23 Jan 2025 |
Direct |
| David C. Paul |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Award |
|
|
|
75,000 |
75,000 |
23 Jan 2025 |
Direct |
| Keith W. Pfeil |
GMED |
Stock Option (Right to Buy Class A Common Stock) |
Award |
|
|
|
60,000 |
60,000 |
23 Jan 2025 |
Direct |